Alkermes plc.（ALKS）内部人交易：高管与董事近期交易
过去 18 个月，共有 15 位内部人为 Alkermes plc.（ALKS）报告了 144 笔 Form 4 交易（最近一笔 2026-10-09）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-09 | Reed Joshua | SVP, Chief Financial Officer | 买入 | 9,164 | $0 |
| 2026-10-09 | Reed Joshua | SVP, Chief Financial Officer | 卖出 | 4,069 | $163,208 |
| 2026-10-02 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $83,455 |
| 2026-09-03 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $97,652 |
| 2026-09-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $122,950 |
| 2026-09-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $422,874 |
| 2026-08-17 | Nichols Christian Todd | SVP, Chief Commercial Officer | 卖出 | 6,912 | $339,967 |
| 2026-08-17 | Nichols Christian Todd | SVP, Chief Commercial Officer | 卖出 | 664 | $32,969 |
| 2026-08-03 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 买入 | 4,896 | $120,393 |
| 2026-08-03 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $98,812 |
| 2026-08-03 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 买入 | 104 | $2,011 |
| 2026-08-03 | snyderman nancy lynn MD | 董事 | 买入 | 16,524 | $772,001 |
| 2026-08-03 | snyderman nancy lynn MD | 董事 | 买入 | 27,948 | $1.3M |
| 2026-08-03 | snyderman nancy lynn MD | 董事 | 卖出 | 44,472 | $2.2M |
| 2026-08-03 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $437,220 |
| 2026-07-06 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $109,897 |
| 2026-07-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $96,700 |
| 2026-07-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 卖出 | 8,300 | $427,129 |
| 2026-07-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 卖出 | 700 | $36,492 |
| 2026-06-12 | Wright Christopher I | 董事 | 卖出 | 2,000 | $90,200 |
| 2026-06-04 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 卖出 | 2,034 | $87,564 |
| 2026-06-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $96,700 |
| 2026-06-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $375,030 |
| 2026-05-29 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | 买入 | 3,392 | $67,942 |
| 2026-05-29 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | 买入 | 12,825 | $248,036 |
来源：SEC Form 4 申报文件 · 截至 2026-10-09